HISTORY
On May 24, 2022, the expanded live vaccine workshop of Yangzhou Hanjiang production base passed the new version of veterinary drug GMP certification.
On December 28, 2021, Sinopharm held a celebration meeting for the 50th anniversary of its establishment.
On December 1, 2021, the new canteen shift dormitory building of Sinopharm animal protection Jiulong base was completed and put into use.
On July 28, 2021, it passed the certification of veterinary drug GCP (veterinary drug clinical trial quality management specification).
On November 15, 2020, the live vaccine workshop, inactivated vaccine workshop and diagnostic workshop of Wuhan Jiulong production base, which were newly built with an investment of 527 million yuan, passed the acceptance of the 2020 version of veterinary drug GMP. Sinopharm has become one of the first batch of veterinary biological products enterprises that have passed the new version of veterinary drug GMP certification in China.
On October 29, 2020, the inactivated vaccine comprehensive workshop of Yangzhou Hanjiang production base with an investment of more than 270 million Yuan passed the acceptance of the 2020 version of veterinary drug GMP.
On October 25, 2020, CNAs laboratory passed the certification of China National Accreditation for conformity assessment.
On June 30, 2019, the production workshop of Wuhan Jiulong production base passed the dynamic acceptance of the 2002 version of veterinary drug GMP.
On December 28, 2018, it was renamed Sinopharm animal health Co., Ltd.
On August 21, 2018, "small ruminant plague and goat pox live vaccine (clone9 + av41)" was approved for production.
On February 11, 2018, through equity exchange, Sinopharm Yangzhou Weike Bioengineering Co., Ltd. became a wholly-owned subsidiary, and the registered capital of the company increased to 25205346 yuan.
On December 1, 2017, the construction of Wuhan Jiulong production base was restarted.
On September 26, 2017, the headquarters of the company settled in Guoyao building.
On December 5, 2016, China Biotechnology Co., Ltd. completed the assets reorganization of the company, and the registered capital of the company increased to 176.4 million yuan.
On February 2, 2016, Wuhan Fenghuang experimental animal base obtained the license for use of experimental animals issued by the Department of science and technology of Hubei Province.
On May 8, 2015, the CPC Wuhan Zhongbo biological Co., Ltd. Committee was established.
On March 30, 2015, the independently developed "porcine circovirus type 2 baculovirus vector inactivated vaccine (cp08 strain)" was approved for production.
On May 16, 2012, the foundation of Wuhan Jiulong animal biological products production base was laid.
On December 5, 2010, a remote video diagnosis center for large-scale pig farms was established in cooperation with Hubei animal disease prevention and control center.
On September 30, 2009, Wuhan Zhongbo biological Co., Ltd. was reorganized as a whole, and the total share capital of the company increased to 65 million yuan.
On September 1, 2009, the technology center of the company was recognized as the enterprise technology center of Hubei Province.
On March 20, 2009, YaoYuan production workshop was established in cooperation with Hubei Academy of Agricultural Sciences.
On May 31, 2007, the company obtained the production license of inactivated vaccine of highly pathogenic porcine blue ear disease (NVDC-JXA1) and became the designated manufacturer of national major animal disease vaccine. The sales revenue of the company exceeded 100 million yuan in that year.
On December 6, 2006, the business of fishery medicine and veterinary medicine was stripped off.
Wuhan zhibote Biotechnology Co., Ltd. was established on December 15, 2006.
On December 12, 2006, Wuhan Yabote Animal Health Management Co., Ltd. was established with American Newport and other companies.
On August 27, 2006, the reconstructed virus inactivated vaccine GMP workshop passed the GMP acceptance of the Ministry of agriculture.
On December 27, 2005, the expanded live virus vaccine workshop and the newly built live bacterial vaccine workshop in Jinkou base passed the GMP acceptance of the Ministry of agriculture.
On July 4, 2005, Wuhan Research Institute of agricultural science and technology transferred 75.2% of the company's equity held by Donghu hi tech and took over the company.
On December 31, 2001, it was reorganized with Wuhan Zhongbo aquatic science and Technology Co., Ltd. and renamed Wuhan Zhongbo Biochemical Co., Ltd.
On May 29, 2001, Wuhan Donghu high tech Anlu veterinary drug factory was established.
On April 15, 1999, a 1000m2 live virus vaccine GMP workshop was built.
On September 15, 1998, Wuhan Donghu high tech Agricultural Bioengineering Co., Ltd. was jointly established with Wuhan Donghu high tech Development Co., Ltd.
On November 13, 1990, it was renamed Hubei biological products factory.
In September 1971, Hubei veterinary biological pharmaceutical factory started construction in Jinshui gate of Wuchang County, and was completed and put into operation in September 1974.
CONTACT US
ADDRESS: building A21, biological innovation park, No. 666, Gaoxin Avenue, Donghu New Technology Development Zone, Wuhan, Hubei Province
Copyright © Sinopharm Animal Health Corporation Ltd. All Rights Reserved. SEO Powered by 300.cn